These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8609538)
1. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention. Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538 [TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. Boelaert JR J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051 [TBL] [Abstract][Full Text] [Related]
3. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis]. Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204 [TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Chow JW; Yu VL Arch Intern Med; 1989 Jun; 149(6):1258-62. PubMed ID: 2658896 [TBL] [Abstract][Full Text] [Related]
6. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Lederer SR; Riedelsdorf G; Schiffl H Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699 [TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122 [TBL] [Abstract][Full Text] [Related]
8. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. Peña C; Fernández-Sabe N; Domínguez MA; Pujol M; Martinez-Castelao A; Ayats J; Gudiol F; Ariza J J Hosp Infect; 2004 Sep; 58(1):20-7. PubMed ID: 15350709 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006 [TBL] [Abstract][Full Text] [Related]
12. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin. Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873 [TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389 [TBL] [Abstract][Full Text] [Related]
15. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin. Al-Hwiesh AK; Abdul Rahman IS Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288 [TBL] [Abstract][Full Text] [Related]
16. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309 [TBL] [Abstract][Full Text] [Related]
17. Mupirocin treatment of nasal staphylococcal colonization. Scully BE; Briones F; Gu JW; Neu HC Arch Intern Med; 1992 Feb; 152(2):353-6. PubMed ID: 1739366 [TBL] [Abstract][Full Text] [Related]
18. Elimination of Staphylococcus aureus in hemodialysis patients. Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240 [TBL] [Abstract][Full Text] [Related]
20. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience. Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]